The Medidata Research Alliance is a collaborative research platform that brings together academic leaders, industry experts, and Medidata's extensive data and technology resources. It aims to leverage historical clinical trial data from over 30,000 cross-sponsor trials to accelerate medical breakthroughs and expand patient access to promising treatments.

Key Features

Robust Data Analytics Utilizes historical clinical trial data for in-depth research and analytics

• Data from over 30,000 cross-sponsor trials
• More than 9 million patients from over 100 countries
• Complete with original endpoints and covariate information

Collaborative Framework Unites leading academics and research scientists with industry experts

• Brings together key opinion leaders and Medidata's expert staff
• Includes clinicians, biostatisticians, former regulatory officials, and industry veterans
• Facilitates collaborative analyses to turn hypotheses into actionable insights

Specialized Research Areas Focuses on various therapeutic areas and research topics

• Immunotherapies and rare diseases
• CAR-T and Bi-specific T-cell Engagers (BiTEs) therapies
• Cardiovascular research
• Synthetic data generation

Benefits

Accelerated Medical Breakthroughs Facilitates faster progress in medical research and treatment strategies

• Explores clinically impactful hypotheses
• Bridges insights from data to clinical practice
• Expands into multiple therapeutic areas

Enhanced Data-Driven Decision Making Enables more informed clinical trial design and patient care

• Uncovers trends in diverse patient populations
• Evaluates therapeutic efficacy, patient outcomes, and safety profiles
• Informs safety events and patient selection in clinical trials

Collaborative Knowledge Sharing Fosters partnerships and knowledge exchange across the medical community

• Co-presentations at global conferences (ASCO, ASH, NCCN, EBMT-EHA)
• Publications in peer-reviewed journals
• Comprehensive library of research and publications through the Medidata Institute